chrX-19355373-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000284.4(PDHA1):c.628A>G(p.Met210Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M210I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000284.4 missense
Scores
Clinical Significance
Conservation
Publications
- Leigh syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- pyruvate dehydrogenase E1-alpha deficiencyInheritance: XL, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000284.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | NM_000284.4 | MANE Select | c.628A>G | p.Met210Val | missense | Exon 7 of 11 | NP_000275.1 | ||
| PDHA1 | NM_001173454.2 | c.742A>G | p.Met248Val | missense | Exon 8 of 12 | NP_001166925.1 | |||
| PDHA1 | NM_001173455.2 | c.649A>G | p.Met217Val | missense | Exon 7 of 11 | NP_001166926.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | ENST00000422285.7 | TSL:1 MANE Select | c.628A>G | p.Met210Val | missense | Exon 7 of 11 | ENSP00000394382.2 | ||
| PDHA1 | ENST00000423505.6 | TSL:2 | c.742A>G | p.Met248Val | missense | Exon 8 of 12 | ENSP00000406473.2 | ||
| PDHA1 | ENST00000417819.6 | TSL:3 | c.712A>G | p.Met238Val | missense | Exon 8 of 12 | ENSP00000404616.2 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
Pyruvate dehydrogenase E1-alpha deficiency Pathogenic:2
PS2, PS3, PM2, PM5
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with pyruvate dehydrogenase E1-alpha deficiency. (I) 0110 - This gene is associated with X-linked dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from methionine to valine. (I) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region in DECIPHER). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been reported as hemizygous in a male patient with pyruvate dehydrogenase complex (PDHC) deficiency (PMID:8844217). It has also been reported as VUS in ClinVar. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1006 - Clinically accredited laboratory assay shows abnormal function of product not specific to the gene. This proband had reduced PDHC activity in fibroblasts and lymphocytes. (SP) 1102 - Strong phenotype match for this individual. (SP) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
not provided Pathogenic:1Uncertain:1
Published functional studies using a yeast model demonstrate decreased enzymatic activity and impairment of the pyruvate dehydrogenase complex accompanied by structural changes (PMID: 29445841); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8844217, 24718837, 33588022, 29445841)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at